Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$27.42 - $43.63 $11,105 - $17,670
-405 Reduced 5.26%
7,291 $226,000
Q1 2022

May 16, 2022

BUY
$36.48 - $52.22 $280,750 - $401,885
7,696 New
7,696 $316,000
Q4 2020

Feb 16, 2021

SELL
$79.17 - $111.47 $213,679 - $300,857
-2,699 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$81.91 - $134.94 $221,075 - $364,203
2,699 New
2,699 $279,000
Q4 2019

Feb 14, 2020

SELL
$51.21 - $59.06 $75,483 - $87,054
-1,474 Closed
0 $0
Q3 2019

Nov 08, 2019

BUY
$40.6 - $57.2 $38,570 - $54,340
950 Added 181.3%
1,474 $77,000
Q2 2019

Aug 12, 2019

SELL
$39.92 - $53.86 $18,962 - $25,583
-475 Reduced 47.55%
524 $25,000
Q1 2019

Apr 29, 2019

BUY
$48.23 - $66.16 $24,259 - $33,278
503 Added 101.41%
999 $50,000
Q4 2018

Jan 28, 2019

BUY
$55.63 - $73.24 $27,592 - $36,327
496 New
496 $29,000

Others Institutions Holding EBS

About Emergent BioSolutions Inc.


  • Ticker EBS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,861,500
  • Market Cap $515M
  • Description
  • Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...
More about EBS
Track This Portfolio

Track Quantamental Technologies LLC Portfolio

Follow Quantamental Technologies LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantamental Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quantamental Technologies LLC with notifications on news.